Full text is available at the source.
Abstract
The study examines the efficacy and safety of intensifying once-weekly insulin icodec with once-weekly semaglutide in adults with type 2 diabetes.
- The combination of insulin icodec and semaglutide is intended for adults with type 2 diabetes.
- This approach focuses on enhancing blood sugar control.
- Efficacy and safety outcomes are being assessed in the context of diabetes management.
- Findings may help inform treatment options for individuals with type 2 diabetes.
Simplified